Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Pharmaceuticals, Inc. - Common Stock
(NQ:
CPRX
)
21.27
-0.19 (-0.89%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,753,345
Open
21.27
Bid (Size)
21.00 (5)
Ask (Size)
21.56 (1)
Prev. Close
21.46
Today's Range
21.01 - 21.41
52wk Range
13.12 - 24.27
Shares Outstanding
102,780,151
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why NASDAQ:CPRX Is a Standout High-Growth Stock in a Consolidation Phase.
December 17, 2024
CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX), a strong growth stock, setting up for a breakout.
Via
Chartmill
Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 16, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Performance
YTD
+24.31%
+24.31%
1 Month
-0.98%
-0.98%
3 Month
+3.81%
+3.81%
6 Month
+38.21%
+38.21%
1 Year
+24.10%
+24.10%
More News
Read More
NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
December 11, 2024
Via
Investor's Business Daily
Don't overlook NASDAQ:CPRX—a stock with solid growth prospects and a reasonable valuation.
December 11, 2024
Via
Chartmill
Unlocking the Growth Potential of NASDAQ:CPRX.
December 11, 2024
Via
Chartmill
Why NASDAQ:CPRX qualifies as a high growth stock.
December 03, 2024
Via
Chartmill
Is NASDAQ:CPRX on the Verge of a Major Breakout as a Strong Growth Stock?
November 25, 2024
Via
Chartmill
NASDAQ:CPRX is showing good growth, while it is not too expensive.
November 20, 2024
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:CPRX remains undervalued.
December 03, 2024
Via
Chartmill
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List
November 25, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
November 19, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
NASDAQ:CPRX is an undervalued gem with solid fundamentals.
November 12, 2024
Via
Chartmill
Why the growth investor may take a look at CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX).
November 07, 2024
Via
Chartmill
A Peek at Catalyst Pharmaceuticals's Future Earnings
November 05, 2024
Via
Benzinga
BioNTech Stock Got A IBD RS Rating Lift
November 14, 2024
Via
Investor's Business Daily
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
November 13, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Vericel Stock Sees RS Rating Shoot Higher
November 11, 2024
Via
Investor's Business Daily
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
Via
Talk Markets
NASDAQ:CPRX, a growth stock which is not overvalued.
October 30, 2024
Via
Chartmill
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
November 06, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Why NASDAQ:CPRX Is a Promising High-Growth Stock in the Midst of Consolidation.
November 04, 2024
Via
Chartmill
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
Via
Talk Markets
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024
October 22, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
October 15, 2024
Via
Investor's Business Daily
NASDAQ:CPRX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
October 14, 2024
Via
Chartmill
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.